OPRX logo

OptimizeRx (OPRX) Selling, General & Administrative Expenses

Annual SGA

$58.02 M
+$8.78 M+17.84%

December 31, 2023


Summary


Performance

OPRX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOPRXexpensesmetrics:

Quarterly SGA

$13.43 M
-$955.00 K-6.64%

September 30, 2024


Summary


Performance

OPRX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOPRXexpensesmetrics:

TTM SGA

-$294.87 M
-$24.17 M-8.93%

September 30, 2024


Summary


Performance

OPRX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOPRXexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

OPRX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.8%0.0%-569.3%
3 y3 years+148.4%+9.5%-987.6%
5 y5 years+463.6%+196.2%-2125.3%

OPRX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+74.8%-28.8%+17.9%-105.8%at low
5 y5-yearat high+298.5%-28.8%+196.2%-135.9%at low
alltimeall timeat high+3857.2%-28.8%+7113.9%-1934.7%at low

OptimizeRx Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$13.43 M(-6.6%)
$62.83 M(+0.9%)
Jun 2024
-
$14.38 M(-11.0%)
$62.29 M(+3.6%)
Mar 2024
-
$16.17 M(-14.3%)
$60.12 M(+3.7%)
Dec 2023
$58.02 M(+17.8%)
$18.86 M(+46.3%)
$57.99 M(+11.5%)
Sep 2023
-
$12.89 M(+5.5%)
$51.99 M(+0.4%)
Jun 2023
-
$12.21 M(-13.0%)
$51.76 M(-0.2%)
Mar 2023
-
$14.03 M(+9.1%)
$51.88 M(+5.4%)
Dec 2022
$49.24 M(+48.3%)
$12.86 M(+1.6%)
$49.24 M(+1.2%)
Sep 2022
-
$12.66 M(+2.8%)
$48.63 M(+10.4%)
Jun 2022
-
$12.32 M(+8.2%)
$44.05 M(+13.9%)
Mar 2022
-
$11.39 M(-7.1%)
$38.66 M(+16.4%)
Dec 2021
$33.19 M(+42.1%)
$12.26 M(+51.7%)
$33.22 M(+20.8%)
Sep 2021
-
$8.08 M(+16.6%)
$27.51 M(+10.5%)
Jun 2021
-
$6.93 M(+16.5%)
$24.89 M(+6.2%)
Mar 2021
-
$5.95 M(-9.2%)
$23.43 M(+0.3%)
Dec 2020
$23.35 M(+60.4%)
$6.55 M(+20.0%)
$23.35 M(+9.4%)
Sep 2020
-
$5.46 M(-0.2%)
$21.34 M(+9.5%)
Jun 2020
-
$5.47 M(-6.9%)
$19.49 M(+12.3%)
Mar 2020
-
$5.87 M(+29.6%)
$17.35 M(+19.2%)
Dec 2019
$14.56 M(+41.4%)
$4.53 M(+25.7%)
$14.56 M(+9.4%)
Sep 2019
-
$3.61 M(+8.2%)
$13.31 M(+7.9%)
Jun 2019
-
$3.33 M(+8.0%)
$12.34 M(+8.4%)
Mar 2019
-
$3.09 M(-6.1%)
$11.39 M(+10.6%)
Dec 2018
$10.29 M(+52.5%)
$3.29 M(+24.6%)
$10.29 M(+12.4%)
Sep 2018
-
$2.64 M(+11.1%)
$9.16 M(+10.2%)
Jun 2018
-
$2.37 M(+19.1%)
$8.31 M(+13.1%)
Mar 2018
-
$1.99 M(-7.3%)
$7.35 M(+8.9%)
Dec 2017
$6.75 M
$2.15 M(+20.0%)
$6.75 M(+7.8%)
Sep 2017
-
$1.79 M(+27.1%)
$6.26 M(+11.2%)
Jun 2017
-
$1.41 M(+1.2%)
$5.63 M(+1.8%)
DateAnnualQuarterlyTTM
Mar 2017
-
$1.39 M(-16.2%)
$5.53 M(+5.5%)
Dec 2016
$5.24 M(+57.7%)
$1.66 M(+43.1%)
$5.24 M(+13.3%)
Sep 2016
-
$1.16 M(-11.2%)
$4.62 M(+10.7%)
Jun 2016
-
$1.31 M(+18.6%)
$4.18 M(+12.5%)
Mar 2016
-
$1.10 M(+5.4%)
$3.71 M(+11.8%)
Dec 2015
$3.32 M(-3.8%)
$1.05 M(+46.1%)
$3.32 M(+14.8%)
Sep 2015
-
$717.00 K(-15.1%)
$2.89 M(-9.8%)
Jun 2015
-
$844.50 K(+18.5%)
$3.21 M(+1.3%)
Mar 2015
-
$712.50 K(+14.9%)
$3.17 M(-8.3%)
Dec 2014
$3.45 M(+22.9%)
$619.90 K(-39.9%)
$3.45 M(-7.1%)
Sep 2014
-
$1.03 M(+28.3%)
$3.72 M(+38.4%)
Jun 2014
-
$803.60 K(-19.6%)
$2.69 M(+42.7%)
Mar 2014
-
$999.20 K(+13.0%)
$1.88 M(+19.9%)
Dec 2013
$2.81 M(+31.3%)
$884.60 K(+29.0%)
$1.57 M(-30.0%)
Mar 2013
-
$685.90 K(+29.6%)
$2.24 M(+4.7%)
Dec 2012
$2.14 M(-11.5%)
$529.20 K(+7.6%)
$2.14 M(-5.5%)
Sep 2012
-
$491.90 K(-8.3%)
$2.27 M(-3.4%)
Jun 2012
-
$536.20 K(-8.2%)
$2.35 M(-2.3%)
Mar 2012
-
$584.30 K(-10.7%)
$2.40 M(-0.8%)
Dec 2011
$2.42 M(+26.2%)
$654.60 K(+14.7%)
$2.42 M(+22.1%)
Sep 2011
-
$570.70 K(-3.4%)
$1.98 M(+1.3%)
Jun 2011
-
$590.60 K(-2.3%)
$1.96 M(-13.4%)
Mar 2011
-
$604.20 K(+179.5%)
$2.26 M(+17.7%)
Dec 2010
$1.92 M(-57.8%)
$216.20 K(-60.4%)
$1.92 M(-51.8%)
Sep 2010
-
$545.90 K(-38.8%)
$3.98 M(-2.0%)
Jun 2010
-
$892.10 K(+238.0%)
$4.06 M(+21.1%)
Mar 2010
-
$263.90 K(-88.4%)
$3.35 M(+8.5%)
Dec 2009
$4.54 M(+209.7%)
$2.28 M(+263.5%)
$3.09 M(+280.2%)
Sep 2009
-
$625.90 K(+236.3%)
$812.00 K(+336.3%)
Jun 2009
-
$186.10 K
$186.10 K
Dec 2008
$1.47 M
-
-

FAQ

  • What is OptimizeRx annual SGA?
  • What is the all time high annual SGA for OptimizeRx?
  • What is OptimizeRx annual SGA year-on-year change?
  • What is OptimizeRx quarterly SGA?
  • What is the all time high quarterly SGA for OptimizeRx?
  • What is OptimizeRx quarterly SGA year-on-year change?
  • What is OptimizeRx TTM SGA?
  • What is the all time high TTM SGA for OptimizeRx?
  • What is OptimizeRx TTM SGA year-on-year change?

What is OptimizeRx annual SGA?

The current annual SGA of OPRX is $58.02 M

What is the all time high annual SGA for OptimizeRx?

OptimizeRx all-time high annual SGA is $58.02 M

What is OptimizeRx annual SGA year-on-year change?

Over the past year, OPRX annual SGA has changed by +$8.78 M (+17.84%)

What is OptimizeRx quarterly SGA?

The current quarterly SGA of OPRX is $13.43 M

What is the all time high quarterly SGA for OptimizeRx?

OptimizeRx all-time high quarterly SGA is $18.86 M

What is OptimizeRx quarterly SGA year-on-year change?

Over the past year, OPRX quarterly SGA has changed by $0.00 (0.00%)

What is OptimizeRx TTM SGA?

The current TTM SGA of OPRX is -$294.87 M

What is the all time high TTM SGA for OptimizeRx?

OptimizeRx all-time high TTM SGA is -$14.49 M

What is OptimizeRx TTM SGA year-on-year change?

Over the past year, OPRX TTM SGA has changed by -$357.70 M (-569.32%)